Nakamoto Holdings and Korean Biotech Firms Secure Funding for Bitcoin Treasury Strategy
Bitcoin's appeal as a treasury asset continues to grow, with Nakamoto Holdings securing an additional $51.5 million in funding. This capital injection, alongside a significant $183.3 million investment in South Korean biotech firm Bridge Biotherapeutics by Parataxis, underscores a global trend of...